Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Presse Medicale (Paris, France : 1983)|December 3, 1994
[Macrolides. New therapeutic prospects]A Bryskier, M T Labro
The Journal of Antimicrobial Chemotherapy|July 1, 1997
Ketolides lack inducibility properties of MLS(B) resistance phenotypeA Bonnefoy, A M Girard, C Agouridas, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebaeM Maurin, A Bryskier, D Raoult
Antimicrobial Agents and Chemotherapy|June 13, 1998
A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycinA Rosato, H Vicarini, A Bonnefoy, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|November 18, 1980
[Septicemia due to polyresistant Staphylococcus aureus (author's transl)]J P Bonnardot, R Bonvoisin, A Bryskier
Journal of Chemotherapy (Florence, Italy)|April 15, 2005
In vitro evaluation of faropenem activity against anaerobic bacteriaJ Behra-Miellet, L Dubreuil, A Bryskier
Antimicrobial Agents and Chemotherapy|July 1, 1993
In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICsN Rastogi, K S Goh, A Bryskier
Pageof 12